Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-24-007100

Options or other derivatives

  • Director acquired 1,531 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dable Habib J · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,531 $16.37 $25,062 1,531 D
Loading xslF345X05/form4-03062024_060321.xml…